Schedule Crashers

How to identify and mitigate risks to keep your timeline on track. Biopharma companies can be an optimistic bunch – at least at the beginning of a project. When they find a molecule that shows promise, they are eager to get it to market as quickly as possible – and...

Sound Clinical Strategies: Wwwwwh?

How asking the right questions during clinical development planning can prevent costly mistakes down the line.   When a biopharma company, and its investors, get excited about a new molecule, it can be easy to dive straight into clinical development. The sooner...

Clinical Trials in Asia: Boom or Bust?

A recent article in Outsourcing Pharma examined the state of clinical trials in China, India and Japan, and whether the recent boom in clinical trials in Asia was likely to turn into a bust.  While we agree with most points in the article, my colleague, Barb Geiger,...